Takeda Pharmaceutical Company Limited Share Price NYSE
Stocks
TAK
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
NYSE
21:00:02 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 18.45 USD | -1.39% |
|
+2.33% | +18.35% |
| 09-04 | After obesity, pharma seeks its next mega-blockbuster in sleep |  |
| 09-04 | Takeda Pharmaceutical Insider Sold Shares Worth $2,148,372, According to a Recent SEC Filing | MT |
| Market Cap | 9,186B 58.86B 50.65B 47.66B 43.53B 81.44B 5,558B 81.66B 563B 219B 2,851B 221B 216B | P/E 2027 * |
45.6x | P/E 2028 * | 29x |
|---|---|---|---|---|---|
| Enterprise Value | 13,093B 83.9B 72.19B 67.92B 62.05B 116B 7,921B 116B 803B 311B 4,064B 315B 308B | EV / Sales 2027 * |
2.79x | EV / Sales 2028 * | 2.7x |
| Free-Float |
99.26% | Yield 2027 * |
3.55% | Yield 2028 * | 3.62% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| TAK | Delayed | |
CBOE
| TAK | Real-time | |
|
London S.E.
| 0A87 | Delayed | |
|
Deutsche Boerse AG
| TKDA | Delayed | |
|
Börse Stuttgart
| TKDA | Delayed | |
|
Tradegate
| TKDA | Real-time | |
|
Boerse Muenchen
| TKDA | Real-time |
Last Transcript : Takeda Pharmaceutical Company Limited
| 1 day | -1.39% | ||
| 1 week | +2.33% | ||
| Current month | +2.61% | ||
| 1 month | +11.41% | ||
| 3 months | +19.42% | ||
| 6 months | +1.26% | ||
| Current year | +18.35% |
| 1 week | 17.96 |  | 18.84 |
| 1 month | 16.91 | | 18.84 |
| Current year | 14.84 | | 18.9 |
| 1 year | 12.99 | | 18.9 |
| 3 years | 12.58 | | 18.9 |
| 5 years | 12.28 | | 18.9 |
| 10 years | 12.28 | | 31.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/2024 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.39% | +2.33% | - | - | 60.63B | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,034B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 671B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 188B | |
| Average | -1.03% | +1.10% | +28.30% | +51.13% | 412.97B | |
| Weighted average by Cap. | -1.11% | +0.51% | +36.62% | +66.21% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,701B 30.12B 25.92B 24.39B 22.28B 41.68B 2,844B 41.79B 288B 112B 1,459B 113B 111B | 4,781B 30.64B 26.37B 24.81B 22.66B 42.39B 2,893B 42.51B 293B 114B 1,484B 115B 113B |
| Net income | 196B 1.26B 1.08B 1.02B 931M 1.74B 119B 1.75B 12.05B 4.67B 60.99B 4.73B 4.63B | 322B 2.07B 1.78B 1.67B 1.53B 2.86B 195B 2.87B 19.77B 7.67B 100B 7.76B 7.59B |
| Net Debt | 3,907B 25.03B 21.54B 20.27B 18.51B 34.63B 2,363B 34.73B 239B 92.93B 1,213B 94B 91.95B | 3,702B 23.72B 20.41B 19.21B 17.55B 32.82B 2,240B 32.91B 227B 88.07B 1,149B 89.08B 87.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$18.45 | -1.39% | 1,499,546 |
| 03/09/26 | US$18.71 | +1.52% | 2,853,635 |
| 02/09/26 | US$18.43 | +1.10% | 1,721,820 |
| 01/09/26 | US$18.23 | +1.39% | 1,899,444 |
| 31/08/26 | US$17.98 | -0.28% | 1,779,519 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
Select your edition
All financial news and data tailored to specific country editions
